Correlation Between Prelude Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Prelude Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prelude Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prelude Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Prelude Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prelude Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prelude Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Prelude Therapeutics and Eliem Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Prelude and Eliem is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Prelude Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Prelude Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prelude Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Prelude Therapeutics i.e., Prelude Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Prelude Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Prelude Therapeutics is expected to under-perform the Eliem Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Prelude Therapeutics is 1.03 times less risky than Eliem Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Eliem Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 251.00 in Eliem Therapeutics on August 24, 2024 and sell it today you would earn a total of 49.00 from holding Eliem Therapeutics or generate 19.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prelude Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Prelude Therapeutics |
| Eliem Therapeutics |
Prelude Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prelude Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Prelude Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prelude Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Prelude Therapeutics vs. Lyra Therapeutics | Prelude Therapeutics vs. Hookipa Pharma | Prelude Therapeutics vs. Cingulate Warrants | Prelude Therapeutics vs. SAB Biotherapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |